摘要
组蛋白脱乙酰酶(HDACs)在调控肿瘤发生和发展过程中多种蛋白的表达和活性中起着至关重要的作用。HDAC活性导致不允许的CHROO通过抹去组蛋白底物中乙酰基的构象,最终形成转录抑制在肿瘤发生中具有重要作用的基因。除组蛋白外,HDACS Deacetylate含有多种非组蛋白,包括参与调控细胞生长、分化和凋亡的转录因子。组蛋白去乙酰化酶抑制剂(Hdaci)是小分子。抑制HDACs,从而调节其生物活性。新的证据表明,非组蛋白的乙酰化在包括mrna在内的各种细胞过程中起着至关重要的作用。稳定性,蛋白质定位和降解。非组蛋白如核因子kappab(nf-кb)、热休克蛋白90(Hsp 90)及相合蛋白(Frataxin)的异常转换或表达包括癌症在内的疾病。本文探讨了HDACi的治疗作用,特别强调对临床相关非组蛋白分子靶点的调控。广泛的细节还提供了非组蛋白蛋白质和它们在疾病状态中的放松管制。 此外,HDACI触发的基础分子机制通过调节来克服疾病状态预定义的目标也得到了启发。本文强烈建议在对因非组蛋白deregula并发症的治疗干预的HDACi希望使用支票电托收,象征式互动.
关键词: 乙酰化,去乙酰化,HATS,HDACS,HDACi,组蛋白,非组蛋白蛋白.
图形摘要
Current Drug Targets
Title:Histone Deacetylase Inhibitors Modulating Non-epigenetic Players: The Novel Mechanism for Small Molecule Based Therapeutic Intervention
Volume: 19 Issue: 6
关键词: 乙酰化,去乙酰化,HATS,HDACS,HDACi,组蛋白,非组蛋白蛋白.
摘要: Histone deacetylases (HDACs) play a crucial role in regulating the expression and activity of myriad of proteins involved in tumour onset and progression. HDAC activity results in a nonpermissive chromatin conformation by erasing acetyl moiety from histone substrates culminating in transcriptional repression of those genes having significant role in tumourigenesis. Apart from histones, HDACs deacetylate a variety of non-histone proteins including transcription factors involved in controlling cell growth, differentiation and apoptosis. Histone deacetylase inhibitors (HDACi) are small-molecules restraining HDACs and hence modulating their biological activity. Emerging evidences suggest that acetylation of non-histone proteins plays a critical role in various cellular processes including mRNA stability, protein localization and degradation. Abnormal turnover or expression of non-histone proteins like nuclear factor- kappaB (NF-κB), heat shock protein 90 (HSP90) and frataxin fuels various diseases including cancer. The present article explores the therapeutic role of HDACi with special emphasis on modulation of clinically relevant non-histone molecular targets. Extensive details regarding the non-histone proteins and their deregulation in disease states have also been provided. Moreover, the underlying molecular mechanism triggered by HDACi to overcome disease states by modulating the predefined targets has also been illuminated. The article strongly suggests the promising use of HDACi in therapeutic intervention against complications arising due to non-histone protein deregulation.
Export Options
About this article
Cite this article as:
Histone Deacetylase Inhibitors Modulating Non-epigenetic Players: The Novel Mechanism for Small Molecule Based Therapeutic Intervention, Current Drug Targets 2018; 19 (6) . https://dx.doi.org/10.2174/1389450117666160527143257
DOI https://dx.doi.org/10.2174/1389450117666160527143257 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Forms of Iron Binding in the Cells and the Chemical Features of Chelation Therapy
Mini-Reviews in Medicinal Chemistry Anesthetic Cardioprotection in Clinical Practice From Proof-of-Concept to Clinical Applications
Current Pharmaceutical Design Recent Clinical Trials of Pharmacologic Cardiovascular Interventions in Patients with Chronic Kidney Disease
Reviews on Recent Clinical Trials Diagnostic and Therapeutic Nanoparticles in Cardiovascular Diseases
Current Pharmaceutical Design Effects of the Antidiabetic Drugs on the Age-Related Atrophy and Sarcopenia Associated with Diabetes Type II.
Current Diabetes Reviews Invasive and Noninvasive Assessment of Exercise-induced Ischemic Diastolic Response Using Pressure Transducers
Current Cardiology Reviews Heat Shock Proteins: Mediators of Atherosclerotic Development
Current Drug Targets The Metabolic Syndrome and the Relevance of Nutrients for its Onset
Recent Patents on Biotechnology Long-Term Effects of Perinatal Glucocorticoid Treatment on the Heart
Current Pediatric Reviews Genomic and Non-genomic Effects of Aldosterone
Current Signal Transduction Therapy Critical Overview of Applications of Genetic Testing in Sport Talent Identification
Recent Patents on DNA & Gene Sequences Mitochondrial Dysfunction and Endoplasmic Reticulum Stress in Diabetic Retinopathy: Mechanistic Insights into High Glucose-Induced Retinal Cell Death
Current Clinical Pharmacology Exosomes: The Messengers of Health and Disease
Current Neuropharmacology Closed-loop Neuropharmacology for Epilepsy: Distant Dream or Future Reality?
Current Neuropharmacology Myogenic Properties of Brain and Cardiac Vessels and their Relation to Disease
Current Vascular Pharmacology Conformations and Assembly of Amyloid Oligomers by Electrospray Ionisation - Ion Mobility Spectrometry - Mass Spectrometry
Current Analytical Chemistry Smoking and Hypertension: Effects on Clinical, Biochemical and Pathological Variables Due to Isolated or Combined Action on Cardiovascular System
Current Pharmaceutical Design Annexin A5 Imaging: An Academic Research – Clinical Trials and Theses
Current Molecular Imaging (Discontinued) High-Density Lipoprotein-Mediated Anti-Atherosclerotic and Endothelial-Protective Effects: A Potential Novel Therapeutic Target in Cardiovascular Disease
Current Pharmaceutical Design The Long Way to Objectify Organ Damage Related to Cocaine Abuse: Oxidative Stress is the Main Culprit
Mini-Reviews in Organic Chemistry